Acute Myeloid Leukemia 101: A Changing Landscape for Pharmacists

Learn more about recent treatment options for AML and how pharmacists can play a key role. 




Acute Myeloid Leukemia is the most common leukemia in adults, however until recently, the treatment toolbox for these patients was limited. Over the last several years, the landscape has changed significantly with the availability of novel targeted agents and oral therapies. 

With this evolution, comes a greater role for pharmacists to participate in the care of the AML patient population and provide medication management and support. 

Learners will gain a foundation for understanding AML treatment and the key roles of the pharmacist in the care of these patients.  

This learning activity is sponsored through an educational grant by Abbvie Canada.

Learning objectives:

By the end of this course, you should be able to:  

Describe the pathophysiology of Acute Myeloid Leukemia (AML) 

Summarize the evolution of AML treatment over the years 

Contrast the goal of treatment: curative, disease control, palliative 

Apply the key roles of the pharmacist to your practice: 

  • Provide patient education 
  • Recognize side effects  
  • Evaluate drug interactions 
  • Recommend supportive care and associated medications 

Course outline:

  • Webinar Recording (1 hour, originally presented on July 27, 2022)
  • Multiple-Choice Exam
  • Program Evaluation

Course at a glance:

Who should take this course:

Pharmacists who want an introduction into the treatment of AML.

Development Team: